Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Sell
3,033
-2,136
-41% -$443K ﹤0.01% 1147
2026
Q1
$1.16M Buy
5,169
+1,302
+34% +$324K 0.01% 876
2025
Q4
$931K Buy
3,867
+151
+4% +$38.6K 0.01% 917
2025
Q3
$1.02M Buy
3,716
+288
+8% +$78.7K 0.01% 861
2025
Q2
$884K Buy
3,428
+354
+12% +$84.4K 0.01% 854
2025
Q1
$688K Buy
+3,074
New +$718K 0.01% 902
2024
Q4
Sell
-940
Closed -$229K 1463
2024
Q3
$229K Buy
+940
New +$210K ﹤0.01% 1265
2022
Q4
Sell
-969
Closed -$212K 1369
2022
Q3
$212K Hold
969
﹤0.01% 1148
2022
Q2
$203K Sell
969
-305
-24% -$64.9K ﹤0.01% 1165
2022
Q1
$309K Hold
1,274
﹤0.01% 1063
2021
Q4
$334K Sell
1,274
-36
-3% -$9.34K ﹤0.01% 1016
2021
Q3
$345K Sell
1,310
-150
-10% -$41K ﹤0.01% 957
2021
Q2
$360K Hold
1,460
﹤0.01% 926
2021
Q1
$283K Buy
1,460
+100
+7% +$20.1K ﹤0.01% 973
2020
Q4
$285K Buy
1,360
+40
+3% +$7.97K ﹤0.01% 866
2020
Q3
$226K Hold
1,320
﹤0.01% 841
2020
Q2
$253K Hold
1,320
﹤0.01% 793
2020
Q1
$204K Sell
1,320
-45
-3% -$7.17K ﹤0.01% 866
2019
Q4
$211K Buy
+1,365
New +$197K ﹤0.01% 941
2015
Q2
Sell
-33
Closed -$2K 2278
2015
Q1
$2K Hold
33
﹤0.01% 2010
2014
Q4
$1K Hold
33
﹤0.01% 2068
2014
Q3
$1K Hold
33
﹤0.01% 2076
2014
Q2
$1K Hold
33
﹤0.01% 2067
2014
Q1
$1K Hold
33
﹤0.01% 2070
2013
Q4
$1K Buy
+33
New +$1.67K ﹤0.01% 2015

Other funds holding RMD

D.A. Davidson & Co's RMD Position: Q2 2026 in Review

D.A. Davidson & Co reduced its ResMed (RMD) stake by 41% in Q2 2026, selling an estimated $443K and leaving 3,033 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

D.A. Davidson & Co first reported a position in RMD in Q4 2013 and has held it in 25 quarters since. The position peaked at $1.16M in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • D.A. Davidson & Co held 3,033 shares of ResMed worth $591K as of Q2 2026.
  • D.A. Davidson & Co sold 2,136 ResMed shares in Q2 2026, an estimated $443K.
  • ResMed made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1147 holding.
  • D.A. Davidson & Co first reported a position in ResMed in Q4 2013 and has held it in 25 quarters since.
  • D.A. Davidson & Co's ResMed position peaked at $1.16M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.